Daiichi Sankyo studies DS-8201a in phase III trials for advanced HER2-positive breast cancer Sep. 4, 2018
IAVI enrolling healthy volunteers for first-in-human study of eOD-GT8 60mer vaccine, adjuvanted Sep. 4, 2018
Jeil Pharmaceutical presents JP-1366, a potent potassium-competitive acid blocker for treating GERD Sep. 4, 2018
An epigenetic signature in non-small cell lung cancer predicts response to anti-PD-1 therapy Sep. 4, 2018
RSS